Autonomix Medical, Inc. is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the peripheral nervous system are diagnosed and treated. Autonomix’s first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with up to 3,000 times greater sensitivity than currently available technologies. They believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.   

Autonomix is initially developing their technology for pancreatic cancer pain and pancreatitis pain, conditions that can cause debilitating pain and need an effective solution. However, their technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.